[Biosimilars or follow-on biologics in dermatology]

MeSH terms

• Biological Products* / chemistry
• Biological Products* / economics
• Biological Products* / pharmacokinetics
• China
• Dermatologic Agents* / chemistry
• Dermatologic Agents* / economics
• Dermatologic Agents* / pharmacokinetics
• Drug Approval / legislation & jurisprudence
• Drug Contamination
• Drug Costs
• Europe
• India
• Marketing / economics
• Marketing / legislation & jurisprudence
• Recombinant Proteins / chemistry
• Recombinant Proteins / economics
• Recombinant Proteins / pharmacokinetics
• Recombinant Proteins / therapeutic use
• Spain
• Therapeutic Equivalency
• United States
• United States Food and Drug Administration